10 July 2023
10 July 2023
More restrictive LGBTQ+ bills are being passed in the US that might negatively impact transgender individuals in clinical trials.
Arvinas will act as the regulatory sponsor of the study in the US while Pfizer will be the acting sponsor.
Vaxart has announced that both groups dosed with the oral bivalent vaccine candidate showed increased antibody responses to norovirus.
The MRI software add-on differentiated patients with neurodegenerative disorders based on white matter differences.
Change in adult ADHD as assessed using Investigator Symptom Report Scale is the trial's primary endpoint.
HMPL 415 is a new selective allosteric inhibitor that targets protein tyrosine phosphatase-2 containing the Src homology-2 domain.
The vaccine aims to deliver a single dose protection and reduce rehospitalisation rates among premature babies after discharge.
The company will carry out a three-month safety follow-up after four weeks of treatment with DSR 2.0.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
